Galecto News

Galecto Anticipates That Its Cash, Cash Equivalents and Investments Will Be Sufficient to Fund Operating Expenses and Cap Requirements for at Least the Next Twelve Mos >GLTO

Dow JonesNov 1 08:31 ET

Galecto Cash, Cash Equivalents, and Investments as of Sept 30 Were $19.7M >GLTO

Dow JonesNov 1 08:31 ET

Express News | Galecto Reports Third Quarter 2024 Financial Results

ReutersNov 1 08:30 ET

Galecto 3Q Loss/Shr $3.39 >GLTO

Dow JonesNov 1 08:30 ET

Galecto 3Q Loss $3.88M >GLTO

Dow JonesNov 1 08:30 ET

Press Release: Galecto Reports Third Quarter 2024 Financial Results

Dow JonesNov 1 08:30 ET

Galecto | 10-Q: Q3 2024 Earnings Report

SECNov 1 08:02 ET · Announcements

Galecto Is Maintained at Outperform by Oppenheimer

Dow JonesOct 17 09:32 ET · Ratings

Galecto Analyst Ratings

BenzingaOct 17 09:20 ET · Ratings

Oppenheimer Maintains Galecto(GLTO.US) With Buy Rating, Cuts Target Price to $10

Moomoo NewsOct 17 08:34 ET · Ratings

Express News | Galecto Inc : Oppenheimer Raises Target Price to $10 From $9

ReutersOct 17 08:15 ET

Galecto Price Target Raised to $10 From $9 at Oppenheimer

TipRanksOct 17 08:15 ET

Oppenheimer Sticks to Its Buy Rating for Galecto (GLTO)

TipRanksOct 17 08:07 ET · Ratings

Galecto Announces the Appointment of Wechsler to Its Board of Directors

TipRanksOct 15 08:46 ET

Express News | Galecto Strengthens Board of Directors With Appointment of DR. Amy Wechsler

ReutersOct 15 08:30 ET

Press Release: Galecto Strengthens Board of Directors With Appointment of Dr. Amy Wechsler

Dow JonesOct 15 08:30 ET

Sector Update: Health Care Stocks Softer Monday Afternoon

MT NewswiresOct 7 13:58 ET

12 Health Care Stocks Moving In Monday's Intraday Session

BenzingaOct 7 12:31 ET

Why Galecto (GLTO) Shares Are Down 27% Today

BenzingaOct 7 11:23 ET

Galecto To Focus On Clinical Stage Compound GB1211; Obtains Global Rights To BRM-1420

RTTNewsOct 7 09:51 ET